PubMed Health⌕ Search

PubMed · 15836574

Neuroleptics in headache.

Abstract

OBJECTIVES: To review the mechanism of action of neuroleptics, the evidence for their efficacy, and their clinical use in headache treatment. BACKGROUND: Neuroleptics and antiemetics have long been used for headache treatment; however, they have not been widely utilized because of general unfamiliarity with them and concerns about their adverse events. With the recent advent of the atypical neuroleptics and their improved adverse event profile, our armamentarium for headache treatment has expanded. In this review, we explore the mechanism of action of these classes of drugs, their adverse events, and the evidence for their efficacy. We also detail our experience with the different drugs and how we use them as both acute and preventive headache therapy. DESIGN: A review of published literature was obtained through a MEDLINE search on the use of neuroleptics in headache therapy. CONCLUSION: Neuroleptics have widespread evidence supporting their use in headache treatment and present an important part of the armaterium against headache.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Hua C Siow, William B Young, Stephen D Silberstein. 2005. Neuroleptics in headache.. https://doi.org/10.1111/j.1526-4610.2005.05074.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Differential pharmacology of atypical antipsychotics: clinical implications.

PURPOSE: Pharmacology of atypical antipsychotics and the clinical implications are reviewed. SUMMARY: Psychiatric disorders, such as schizophrenia and bipolar disorder, are often associated with poor outcomes. Atypical antipsychotics have become the standard of care for these disorders, and multiple agents have demonstrated efficacy for both acute and maintenance therapy. As a result of their differential pharmacologic properties, atypical antipsychotics have diverse clinical profiles, resulting in different liabilities for specific adverse events. These effects can, in turn, have an adverse impact on patient functionality, adherence to therapy, and overall health. CONCLUSION: Atypical antipsychotics have distinct pharmacological profiles which result in clinically meaningful differences in adverse effects. Clinicians should have a wide choice of agents available with which to optimize outcomes in the majority of patients with psychiatric disorders.

Antipsychotic Agents↗